To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets
A Relative Bioavailability Study of Diclofenac Sodium 50 mg Enteric-Coated Tablets
To demonstrate the relative bioavailability of Diclofenac Sodium 50 mg enteric-coated tablets.
Diclofenac Sodium 50 mg Tablets (Geneva Pharmaceuticals, Inc)
Voltaren 50 mg Tablets (Geigy Pharmaceuticals)
Inclusion Criteria: No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening. Exclusion Criteria: Positive test results for HIV or hepatitis B or C. Treatment for drug or alcohol dependence.